Skip to content
healthcare.dev

Tavaborole

NDC 70771-1826, Tavaborole, solution, from Zydus Lifesciences Limited.

Product NDC
70771-1826
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
SOLUTION
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212294
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1826 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TAVABOROLE43.5 mg/mL

Pharmacologic classes

Boron Compounds [CS]; Oxaborole Antifungal [EPC]; Protein Synthesis Inhibitors [MoA]

Package NDCNDC-11Package
70771-1826-0707711826001 BOTTLE, WITH APPLICATOR in 1 CARTON (70771-1826-0) / 10 mL in 1 BOTTLE, WITH APPLICATOR

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/15bc62dc-4f5e-4d43-a125-d1f00bee84a5

Use it

Look up 70771-1826 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1826 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1826. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.